Accenture Announces Investment In Israel-based Geneyx - Quick Facts

Accenture (ACN) said it has made a strategic investment, through Accenture Ventures, in Geneyx Genomex Ltd., a developer of genomic analysis and interpretation software. Terms of the investment were not disclosed.

Geneyx offers a NGS data analysis and interpretation platform, harnessing genetic data to guide digital insights for rare and germline disorders. Its AI-based analysis platform streamlines the diagnostics process.

David Yizhar, Geneyx CEO, said, "Accenture's investment and support will enable Geneyx to accelerate the adoption of our AI-based genomic interpretation technology on a global scale."

Geneyx is part of Accenture Ventures' Project Spotlight which offers extensive access to Accenture's domain expertise and its enterprise clients.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Microsoft Corp. (MSFT) said it plans to acquire Activision Blizzard Inc. (ATVI) for $95.00 per share, in an all-cash deal valued at $68.7 billion, inclusive of Activision Blizzard's net cash. The planned acquisition includes iconic franchises from the Activision, Blizzard and King studios like Warcraft,... Goldman Sachs Group Inc. reported Tuesday that profit for the fourth quarter declined 13 percent from last year, reflecting an 8 percent drop in net revenues, higher operating expenses and higher provisions for bad loans. Earnings for the quarter missed analysts' expectations, but quarterly revenues topped it. Amazon has dropped its earlier plan to stop accepting credit cards issued by Visa Inc. in the United Kingdom. The e-commerce giant said it is working on a potential solution with the payments processor to resolve a dispute over the payment fees. In an email to customers, the company reportedly said, "The expected change regarding the use of Visa credit cards on Amazon.co.uk will no longer take...
Follow RTT